Robert O'Hare - 18 Aug 2025 Form 4 Insider Report for Affirm Holdings, Inc. (AFRM)

Role
Chief Financial Officer
Signature
/s/ Josh Samples, Attorney-in-Fact
Issuer symbol
AFRM
Transactions as of
18 Aug 2025
Net transactions value
-$345,042
Form type
4
Filing time
20 Aug 2025, 18:02:36 UTC
Previous filing
09 Jul 2025
Next filing
22 Aug 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
O'Hare Robert Chief Financial Officer 650 CALIFORNIA STREET, SAN FRANCISCO /s/ Josh Samples, Attorney-in-Fact 20 Aug 2025 0001633877

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AFRM Class A Common Stock Options Exercise $510,286 +10,414 $49.00 10,414 18 Aug 2025 Direct F1
transaction AFRM Class A Common Stock Options Exercise $57,072 +991 +9.5% $57.59 11,405 18 Aug 2025 Direct F1
transaction AFRM Class A Common Stock Sale $912,400 -11,405 -100% $80.00 0 18 Aug 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AFRM Stock Option (Right to Buy) Options Exercise $0 -10,414 -33% $0.000000 20,829 18 Aug 2025 Class A Common Stock 10,414 $49.00 Direct F1, F2
transaction AFRM Stock Option (Right to Buy) Options Exercise $0 -991 -3.3% $0.000000 29,071 18 Aug 2025 Class A Common Stock 991 $57.59 Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 6, 2024.
F2 Stock option vests with respect to 5% of the shares of Class A Common Stock underlying the stock option on the six-month anniversary of January 1, 2021, the vesting commencement date, and the remainder of the grant will vest in quarterly installments over a period of four years, in annual aggregate amounts equal to 15%, 20%, 30% and 30%, respectively, subject to the Reporting Person's continued employment with the Issuer as of each vesting date. The Reporting Person can elect to exercise the stock option at any time, provided that the shares acquired upon exercise remain subject to the applicable vesting schedule.
F3 The stock options vest in 48 equal monthly installments beginning December 1, 2024, subject to the Reporting Person's continuous service with the Issuer as of each vesting date.